Patents by Inventor Binchen MAO

Binchen MAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and method for determining Cetuximab sensitivity on gastric cancer
    Patent number: 11459618
    Abstract: A panel of gene expression markers for gastric cancer patient treated or to be treated by cetuximab is provided. Methods and compositions are also provided, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a gastric cancer patient's response to cetuximab.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: October 4, 2022
    Assignee: CROWN BIOSCIENCE, INC. (TAICANG)
    Inventors: Binchen Mao, Sheng Guo, Henry Qixiang Li
  • System and method for determining Kareniticin sensitivity on cancer
    Patent number: 11339447
    Abstract: Provided in the disclosure relates to a panel of gene expression markers for cancer patient treated or to be treated by karenitecin. The disclosure provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a cancer patient's response to karenitecin. Such information can be used in determining prognosis and treatment options for cancer patients.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: May 24, 2022
    Assignee: CROWN BIOSCIENCE, INC. (TAICANG)
    Inventors: Binchen Mao, Dawei Chen, Sheng Guo, Henry Qixiang Li
  • SYSTEM AND METHOD FOR DETERMINING KARENETICIN SENSITIVITY ON CANCER
    Publication number: 20210079477
    Abstract: Provided in the disclosure relates to a panel of gene expression markers for cancer patient treated or to be treated by karenitecin. The disclosure provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a cancer patient's response to karenitecin. Such information can be used in determining prognosis and treatment options for cancer patients.
    Type: Application
    Filed: March 28, 2018
    Publication date: March 18, 2021
    Inventors: Binchen MAO, Dawei CHEN, Sheng GUO, Henry Qixiang LI
  • SYSTEM AND METHOD FOR DETERMINING CETUXIMAB SENSITIVITY ON GASTRIC CANCER
    Publication number: 20200071769
    Abstract: A panel of gene expression markers for gastric cancer patient treated or to be treated by cetuximab is provided. Methods and compositions are also provided, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a gastric cancer patient's response to cetuximab.
    Type: Application
    Filed: March 28, 2018
    Publication date: March 5, 2020
    Inventors: Binchen MAO, Sheng GUO, Henry Qixiang LI